<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v3.0 20080202//EN" "archivearticle3.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?DTDIdentifier.IdentifierValue -//NLM//DTD Journal Publishing DTD v2.0 20040830//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName journalpublishing.dtd?><?SourceDTD.Version 2.0?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 2?><front><journal-meta><journal-id journal-id-type="nlm-ta">PLoS One</journal-id><journal-id journal-id-type="publisher-id">plos</journal-id><journal-id journal-id-type="pmc">plosone</journal-id><journal-title-group><journal-title>PLoS ONE</journal-title></journal-title-group><issn pub-type="epub">1932-6203</issn><publisher><publisher-name>Public Library of Science</publisher-name><publisher-loc>San Francisco, USA</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">09-PONE-RA-12748R1</article-id><article-id pub-id-type="doi">10.1371/journal.pone.0007942</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="Discipline"><subject>Diabetes and Endocrinology/Bone and Mineral Metabolism</subject><subject>Rheumatology/Bone and Mineral Metabolism</subject><subject>Women's Health/Menopause and Post-Reproductive Women's Health</subject></subj-group></article-categories><title-group><article-title>Absence of ERR&#x003b1; in Female Mice Confers Resistance to Bone Loss Induced by Age or Estrogen-Deficiency</article-title><alt-title alt-title-type="running-head">ERR&#x003b1; and Bone Loss</alt-title></title-group><contrib-group><contrib contrib-type="author" equal-contrib="yes"><name><surname>Teyssier</surname><given-names>Catherine</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" equal-contrib="yes"><name><surname>Gallet</surname><given-names>Marl&#x000e8;ne</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Rabier</surname><given-names>B&#x000e9;n&#x000e9;dicte</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Monfoulet</surname><given-names>Laurent</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Dine</surname><given-names>Julien</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Macari</surname><given-names>Claire</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Espallergues</surname><given-names>Julie</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author"><name><surname>Horard</surname><given-names>B&#x000e9;atrice</given-names></name><xref ref-type="aff" rid="aff4"><sup>4</sup></xref></contrib><contrib contrib-type="author"><name><surname>Gigu&#x000e8;re</surname><given-names>Vincent</given-names></name><xref ref-type="aff" rid="aff5"><sup>5</sup></xref></contrib><contrib contrib-type="author"><name><surname>Cohen-Solal</surname><given-names>Martine</given-names></name><xref ref-type="aff" rid="aff6"><sup>6</sup></xref></contrib><contrib contrib-type="author"><name><surname>Chassande</surname><given-names>Olivier</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Vanacker</surname><given-names>Jean-Marc</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1"><sup>&#x0002a;</sup></xref></contrib></contrib-group><aff id="aff1"><label>1</label><addr-line>Institut de G&#x000e9;nomique Fonctionnelle de Lyon, Universit&#x000e9; de Lyon, Universit&#x000e9; Lyon 1, Centre National de la Recherche Scientifique, Institut National de la Recherche Agronomique, Ecole Normale Sup&#x000e9;rieure de Lyon, Lyon, France</addr-line></aff><aff id="aff2"><label>2</label><addr-line>Institut National de la Sant&#x000e9; et de la Recherche M&#x000e9;dicale U 577, Universit&#x000e9; Victor Segalen Bordeaux II, Bordeaux, France</addr-line></aff><aff id="aff3"><label>3</label><addr-line>Institut National de la Sant&#x000e9; et de la Recherche M&#x000e9;dicale U710, Universit&#x000e9; de Montpellier II, Montpellier, France</addr-line></aff><aff id="aff4"><label>4</label><addr-line>Laboratoire de Biologie Mol&#x000e9;culaire de la Cellule, CNRS UMR5239, Ecole Normale Sup&#x000e9;rieure de Lyon, Villeurbanne, France</addr-line></aff><aff id="aff5"><label>5</label><addr-line>The Rosalind and Morris Goodman Cancer Centre, Montr&#x000e9;al, Canada</addr-line></aff><aff id="aff6"><label>6</label><addr-line>Institut National de la Sant&#x000e9; et de la Recherche M&#x000e9;dicale U606, H&#x000f4;pital Lariboisi&#x000e8;re, Paris, France</addr-line></aff><contrib-group><contrib contrib-type="editor"><name><surname>Agarwal</surname><given-names>Sudha</given-names></name><role>Editor</role><xref ref-type="aff" rid="edit1"/></contrib></contrib-group><aff id="edit1">Ohio State University, United States of America</aff><author-notes><corresp id="cor1">&#x0002a; E-mail: <email>jean-marc.vanacker@ens-lyon.fr</email></corresp><fn fn-type="con"><p>Conceived and designed the experiments: MCS OC JMV. Performed the experiments: CT MG BR LM JD CM JE BH. Analyzed the data: MCS OC JMV. Contributed reagents/materials/analysis tools: VG. Wrote the paper: MCS OC JMV.</p></fn></author-notes><pub-date pub-type="collection"><year>2009</year></pub-date><pub-date pub-type="epub"><day>20</day><month>11</month><year>2009</year></pub-date><volume>4</volume><issue>11</issue><elocation-id>e7942</elocation-id><history><date date-type="received"><day>7</day><month>9</month><year>2009</year></date><date date-type="accepted"><day>13</day><month>10</month><year>2009</year></date></history><permissions><copyright-statement>Teyssier et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</copyright-statement></permissions><abstract><sec><title>Background</title><p>ERR&#x003b1; is an orphan member of the nuclear hormone receptor superfamily, which acts as a transcription factor and is involved in various metabolic processes. ERR&#x003b1; is also highly expressed in ossification zones during mouse development as well as in human bones and cell lines. Previous data have shown that this receptor up-modulates the expression of osteopontin, which acts as an inhibitor of bone mineralization and whose absence results in resistance to ovariectomy-induced bone loss. Altogether this suggests that ERR&#x003b1; may negatively regulate bone mass and could impact on bone fragility that occurs in the absence of estrogens.</p></sec><sec><title>Methods/Principal Findings</title><p>In this report, we have determined the <italic>in vivo</italic> effect of ERR&#x003b1; on bone, using knock-out mice. Relative to wild type animals, female ERR&#x003b1;KO bones do not age and are resistant to bone loss induced by estrogen-withdrawal. Strikingly male ERR&#x003b1;KO mice are indistinguishable from their wild type counterparts, both at the unchallenged or gonadectomized state. Using primary cell cultures originating from ERR&#x003b1;KO bone marrow, we also show that ERR&#x003b1; acts as an inhibitor of osteoblast differentiation.</p></sec><sec><title>Conclusion/Significance</title><p>Down-regulating ERR&#x003b1; could thus be beneficial against osteoporosis.</p></sec></abstract><counts><page-count count="6"/></counts></article-meta></front><body><sec id="s1"><title>Introduction</title><p>Bone is a highly dynamic tissue subjected to active remodeling, an equilibrium between construction by osteoblasts and resorption by osteoclasts. Osteoblast are derived from mesenchymal stem cells (MSCs) and their differentiation is promoted by various factors such as the transcription factors Osterix and Runx2 <xref ref-type="bibr" rid="pone.0007942-Ducy1">&#x0005b;1&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="pone.0007942-Komori1">&#x0005b;3&#x0005d;</xref>. Mature osteoblasts express receptor activator of nuclear factor-&#x003ba;B ligand (RANKL), a protein that will signal through RANK, a member of the tumor necrosis factor receptor superfamily present at the surface of pre-osteoclasts, and induce differentiation of these cells <xref ref-type="bibr" rid="pone.0007942-Kostenuik1">&#x0005b;4&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="pone.0007942-Asagiri1">&#x0005b;7&#x0005d;</xref>. On another hand, osteoblasts, as well as other cell types, also express and secrete osteoprotegerin (opg), a decoy receptor that traps RANKL in the extracellular milieu, preventing it from acting on pre-osteoclasts, and thus inhibiting the differentiation of osteoclasts <xref ref-type="bibr" rid="pone.0007942-Simonet1">&#x0005b;8&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0007942-Boyce1">&#x0005b;9&#x0005d;</xref>.</p><p>Stability of bone remodeling also requires other diffusible factors among which estrogens are instrumental. This is particularly illustrated after menopause in aging women, when the fall of circulating level of estrogens leads to enhanced bone remodeling with an excessive resorption <xref ref-type="bibr" rid="pone.0007942-Syed1">&#x0005b;10&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0007942-Raisz1">&#x0005b;11&#x0005d;</xref>. The resulting osteoporosis syndrome is associated with an enhanced fracture risk. Various means are currently available to prevent and treat osteoporosis, most of which mainly aim at inhibiting the excess of bone resorption. These include for example the use of estrogens (natural or synthetic) or of bisphosphonate to reduce osteoclast differentiation or induce their apoptosis, respectively <xref ref-type="bibr" rid="pone.0007942-Raisz1">&#x0005b;11&#x0005d;</xref>.</p><p>The effects of estrogens are mediated by two estrogen receptors (ERs) &#x003b1; and &#x003b2;, which act as ligand-dependent transcription factors and belong to the nuclear receptor superfamily <xref ref-type="bibr" rid="pone.0007942-Laudet1">&#x0005b;12&#x0005d;</xref>. This family also comprises so-called orphan receptors, <italic>i.e.</italic> for which no ligand has been identified to date <xref ref-type="bibr" rid="pone.0007942-Gigure1">&#x0005b;13&#x0005d;</xref>. Estrogen-Receptor Related receptor &#x003b1; (ERR&#x003b1;) was among the first orphan receptors isolated, based on its sequence similarity to ER&#x003b1; <xref ref-type="bibr" rid="pone.0007942-Gigure2">&#x0005b;14&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0007942-Tremblay1">&#x0005b;15&#x0005d;</xref>. Despite this close proximity, ERR&#x003b1; does not bind estrogen nor any identified natural ligand <xref ref-type="bibr" rid="pone.0007942-Horard1">&#x0005b;16&#x0005d;</xref>. ERR&#x003b1; is expressed in several tissues both during embryonic development and in the adult <xref ref-type="bibr" rid="pone.0007942-Bonnelye1">&#x0005b;17&#x0005d;</xref>. A number of studies have identified ERR&#x003b1; as a major actor in the regulation of energy metabolism in oxidative tissues such as heart or slow-twitch skeletal muscle &#x0005b;18, 19 for reviews&#x0005d;. This receptor is indeed involved in the regulation of energy uptake, storage and consumption as well as in mitochondrial biogenesis and function and cardiac response to stress. Most of these effects are thought to depend on the PGC-1&#x003b1; coactivator, with which ERR&#x003b1; physically interacts. High expression of ERR&#x003b1; in various human tumors (originating from such organ as breast, colon and ovary) correlates with a poor prognosis <xref ref-type="bibr" rid="pone.0007942-Ariazi1">&#x0005b;reviewed in 20&#x0005d;</xref>. Proliferation of various cancer cell lines can be inhibited by a synthesis modulator of ERR&#x003b1;, but not by its mere siRNA-mediated knocking-down <xref ref-type="bibr" rid="pone.0007942-Bianco1">&#x0005b;21&#x0005d;</xref>. ERR&#x003b1; is highly expressed in all ossification zones during mouse development, as well as in osteoblastic lines and normal human bones <xref ref-type="bibr" rid="pone.0007942-Bonnelye2">&#x0005b;22&#x0005d;</xref>. Furthermore, a polymorphic variant of the human ERR&#x003b1; promoter has been associated with variable bone mineral density (BMD) in premenopausal women <xref ref-type="bibr" rid="pone.0007942-Laflamme1">&#x0005b;23&#x0005d;</xref>. Although the molecular functions of ERR&#x003b1; in bone cells have not been determined, osteopontin (opn), an inhibitor of bone mineralization <xref ref-type="bibr" rid="pone.0007942-Reinholt1">&#x0005b;24&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="pone.0007942-Kavukcuoglu1">&#x0005b;30&#x0005d;</xref>, has been identified as a positive ERR&#x003b1; transcriptional target <xref ref-type="bibr" rid="pone.0007942-Vanacker1">&#x0005b;31&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="pone.0007942-Zirngibl1">&#x0005b;33&#x0005d;</xref>.</p><p>Here, we show that ERR&#x003b1;KO female mice resist to age-induced bone loss and present a more elevated bone formation rate as compared to wild type animals. Remarkably, ERR&#x003b1; deficiency also conferred resistance to bone loss induced by estrogen withdrawal. Noteworthy, no phenotype was observed in the bones of ERR&#x003b1;-deficient males. ERR&#x003b1;KO originating MSCs displayed enhanced capacities to differentiate into osteoblasts, together with a lower opn expression, as compared to wt MSCs. Altogether our results reveal the role of ERR&#x003b1; in the control of bone density and suggest important cross talks between ERR&#x003b1; and hormonal signalling pathways in bone physiology.</p></sec><sec id="s2"><title>Results and Discussion</title><sec id="s2a"><title>ERR&#x003b1; Deficiency Affects Bone Aging in Female, but Not in Male, Mice</title><p>The structural parameters of cortical and trabecular bone were measured in the femur diaphysis and metaphysis, respectively, of wild type (wt) and ERR&#x003b1; knockout female mice at 14 and 24 weeks. Cortical bone mineral density (BMD) and thickness augmented with age in a similar manner in both genotypes (<xref ref-type="fig" rid="pone-0007942-g001">Fig. 1A and B</xref>). The trabecular mineral density (TMD) was slightly more elevated (but not statistically significant) in wt animals as compared to ERR&#x003b1;KO, but significantly increased with time in the latter genotype (<xref ref-type="fig" rid="pone-0007942-g001">Fig. 1C</xref>). Lower trabecular bone volume (BV/TV; <xref ref-type="fig" rid="pone-0007942-g001">Fig. 1D</xref>) and trabecular number (TbN; <xref ref-type="fig" rid="pone-0007942-g001">Fig. 1E</xref>) were observed in ERR&#x003b1;KO animals relative to wt ones at 14 wk. Interestingly whereas these two parameters were significantly reduced at 24 wk in wt animals as an effect of age, no significant variation occurred in ERR&#x003b1;KO mice. These results indicate that ERR&#x003b1;KO female mice, although deficient in bone trabeculae at maturity (14 wk), are resistant to age-related bone loss. Strikingly no difference was observed in any of the structural parameters of both cortical and trabecular bone between wild type and mutant male mice (<xref ref-type="table" rid="pone-0007942-t001">Table 1</xref>), indicating a gender-dependent effect of the absence of ERR&#x003b1;.</p><fig id="pone-0007942-g001" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0007942.g001</object-id><label>Figure 1</label><caption><title>Bone phenotype of ERR&#x003b1;KO females mice.</title><p>Cortical bone mineral density (BMD; <bold>A</bold>), cortical thickness (<bold>B</bold>), trabecular mineral density (TMD; <bold>C</bold>), bone volume fraction (BV/TV; <bold>D</bold>) and trabecular number (TbN; <bold>E</bold>) were determined at 14 (white bars) and 24 wk (black bars) in the femur of female wt and ERR&#x003b1;KO mice (n&#x0200a;&#x0003d;&#x0200a;6 to 9). Errors bars represent s.e.m. ns: not significant; &#x0002a;:p&#x0003c;0.05; &#x0002a;&#x0002a;&#x0002a; p&#x0003c;0.005.</p></caption><graphic xlink:href="pone.0007942.g001"/></fig><table-wrap id="pone-0007942-t001" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0007942.t001</object-id><label>Table 1</label><caption><title>Trabecular bone parameters of wt and ERR&#x003b1;KO male mice (n&#x0200a;&#x0003d;&#x0200a;8 to 10).</title></caption><alternatives><graphic id="pone-0007942-t001-1" xlink:href="pone.0007942.t001"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup><thead><tr><td align="left" rowspan="1" colspan="1"/><td colspan="2" align="center" rowspan="1">14 wk</td><td colspan="2" align="center" rowspan="1">24 wk</td><td colspan="2" align="center" rowspan="1">Orx<xref ref-type="table-fn" rid="nt101">1</xref></td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">wt</td><td align="left" rowspan="1" colspan="1">ERR&#x003b1;KO</td><td align="left" rowspan="1" colspan="1">wt</td><td align="left" rowspan="1" colspan="1">ERR&#x003b1;KO</td><td align="left" rowspan="1" colspan="1">wt</td><td align="left" rowspan="1" colspan="1">ERR&#x003b1;KO</td></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">TMD<xref ref-type="table-fn" rid="nt102">2</xref> (mg/cc)</td><td align="left" rowspan="1" colspan="1"><bold>752</bold> &#x0002b;/&#x02212; 43</td><td align="left" rowspan="1" colspan="1"><bold>770</bold> &#x0002b;/&#x02212; 33</td><td align="left" rowspan="1" colspan="1"><bold>731</bold> &#x0002b;/&#x02212; 8</td><td align="left" rowspan="1" colspan="1"><bold>694</bold> &#x0002b;/&#x02212; 7</td><td align="left" rowspan="1" colspan="1"><bold>598</bold> &#x0002b;/&#x02212; 14</td><td align="left" rowspan="1" colspan="1"><bold>570</bold> &#x0002b;/&#x02212; 19</td></tr><tr><td align="left" rowspan="1" colspan="1">BV/TV<xref ref-type="table-fn" rid="nt103">3</xref> (&#x00025;)</td><td align="left" rowspan="1" colspan="1"><bold>19.3</bold> &#x0002b;/&#x02212; 1.9</td><td align="left" rowspan="1" colspan="1"><bold>19</bold> &#x0002b;/&#x02212; 0.7</td><td align="left" rowspan="1" colspan="1"><bold>9.4</bold> &#x0002b;/&#x02212; 0.8</td><td align="left" rowspan="1" colspan="1"><bold>10</bold> &#x0002b;/&#x02212; 0.4</td><td align="left" rowspan="1" colspan="1"><bold>5.9</bold> &#x0002b;/&#x02212; 0.2</td><td align="left" rowspan="1" colspan="1"><bold>5.5</bold> &#x0002b;/&#x02212; 0.5</td></tr><tr><td align="left" rowspan="1" colspan="1">TbN<xref ref-type="table-fn" rid="nt104">4</xref> (/mm)</td><td align="left" rowspan="1" colspan="1"><bold>7.7</bold> &#x0002b;/&#x02212; 0.6</td><td align="left" rowspan="1" colspan="1"><bold>7.5</bold> &#x0002b;/&#x02212; 0.4</td><td align="left" rowspan="1" colspan="1"><bold>4.7</bold> &#x0002b;/&#x02212; 0.3</td><td align="left" rowspan="1" colspan="1"><bold>4.5</bold> &#x0002b;/&#x02212; 0.5</td><td align="left" rowspan="1" colspan="1"><bold>3.6</bold> &#x0002b;/&#x02212; 0.3</td><td align="left" rowspan="1" colspan="1"><bold>3.9</bold> &#x0002b;/&#x02212; 0.3</td></tr></tbody></table></alternatives><table-wrap-foot><fn id="nt101"><label>1</label><p>: orchidectomized animals.</p></fn><fn id="nt102"><label>2</label><p>: trabecular mineral density.</p></fn><fn id="nt103"><label>3</label><p>: bone volume/tissue volume.</p></fn><fn id="nt104"><label>4</label><p>: trabecular number.</p></fn></table-wrap-foot></table-wrap><p>The evolution of bone between wild type and ERR&#x003b1;KO females prompted us to examine the parameters of bone resorption and bone formation at 14 wk of age (<italic>i.e.</italic> before a significant difference could be observed between genotypes). Bone formation rate, which represent the activity of osteoblasts, was more elevated in ERR&#x003b1;KO females than in wt animals (<xref ref-type="fig" rid="pone-0007942-g002">Fig. 2A</xref>). The surface occupied by osteoblasts was identical in both genotypes (<xref ref-type="fig" rid="pone-0007942-g002">Fig. 2B</xref>). Serum markers of bone resorption (C-terminal fragment of collagen 1 &#x0005b;Ctx&#x0005d;, indicative of osteoclast activity) were not different between wild type and mutant females, indicating that bone resorption was not affected by the ERR&#x003b1; deficiency (<xref ref-type="fig" rid="pone-0007942-g002">Fig. 2C</xref>). Consistently, a comparable number of osteoclasts (<xref ref-type="fig" rid="pone-0007942-g002">Fig. 2D</xref>), spaning an identical relative surface (<xref ref-type="fig" rid="pone-0007942-g002">Fig. 2E</xref>) were detected in both strains.</p><fig id="pone-0007942-g002" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0007942.g002</object-id><label>Figure 2</label><caption><title>Dynamic parameters of ERR&#x003b1;KO female mice.</title><p>Bone formation rate (BFR; <bold>A</bold>) and mineralizing surface per trabecular bone surface (MS/BS; <bold>B</bold>) were measured in the metaphysis of 14 wk old mice. <bold>C</bold>) Concentration of the C-terminal fragments of collagen 1 (Ctx) were measured in the serum of 14 wk old females. Osteoclast number per bone perimeter (OCn/Bp; <bold>D</bold>) and osteoclast surface per bone surface (OCs/Bs; <bold>E</bold>). n&#x0200a;&#x0003d;&#x0200a;8. White bars: wild type; black bars: ERR&#x003b1;KO mice. Error bars represent s.e.m. ns: not significant; &#x0002a;:p&#x0003c;0.05.</p></caption><graphic xlink:href="pone.0007942.g002"/></fig><p>Altogether this suggests that the resistance of ERR&#x003b1;KO animals to age-induced bone loss could be due to an enhanced osteoblastic activity, and not to variation in osteoclast-related parameters.</p></sec><sec id="s2b"><title>ERR&#x003b1; Negatively Regulates Osteoblast Differentiation</title><p>We thus analyzed the capacities of ERR&#x003b1;KO bone marrow mesenchymal cells to differentiate into osteoblasts <italic>ex vivo</italic>. After seven days in the appropriate medium, ERR&#x003b1; mutant cells produced a greater number of differentiation foci as estimated by alkaline phosphatase (ALP) staining (<xref ref-type="fig" rid="pone-0007942-g003">Fig. 3A</xref>). This was accompanied by a higher mineralization activity, as revealed by von Kossa staining. As measured by quantitative PCR, the expression of various osteoblast differentiation markers, such as Runx-2, ALP or osteocalcin was found more elevated in ERR&#x003b1;KO cells by quantitative PCR. In contrast, opn, an ERR&#x003b1; target gene <xref ref-type="bibr" rid="pone.0007942-Vanacker1">&#x0005b;31&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="pone.0007942-Zirngibl1">&#x0005b;33&#x0005d;</xref>, was less expressed in ERR&#x003b1;KO cells than in wild type cells. We also analyzed the kinetics of ALP expression during osteoblast differentiation (<xref ref-type="fig" rid="pone-0007942-g003">Fig. 3B</xref>). In ERR&#x003b1;KO cells, ALP expression followed the same profile as in wild-type cells but was more elevated at each time point. The phenotype displayed by mutant cells was rescued by infection with an ERR&#x003b1;-encoding adenovirus (AdERR&#x003b1;; <xref ref-type="fig" rid="pone-0007942-g003">Fig. 3C</xref>). Indeed, ALP staining was reduced by AdERR&#x003b1; infection as compared to cells infected with a GFP-encoding adenovirus. AdERR&#x003b1; also reduced the mRNA expression of Runx-2, ALP and osteocalcin. This repression was not a general, non-specific phenomenon since osteopontin expression was enhanced by AdERR&#x003b1;, as expected. This suggests that the capacities of MSCs to differentiate into osteoblasts are enhanced in the absence of ERR&#x003b1; and that the number of precursor cells is not modified. The results above may reflect an effect of the absence of ERR&#x003b1; on osteoblast proliferation rather than on differentiation. To evaluate this hypothesis, we determined the growth capacities of bone marrow cells (<xref ref-type="fig" rid="pone-0007942-g003">Fig. 3D</xref>). ERR&#x003b1;KO cells displayed identical growth rate as wild-type cells, as estimated by determining cell number after 3 and 7 days in culture. However, under these conditions, ERR&#x003b1;KO cells still displayed a higher ALP expression as measured by staining and mRNA expression. We thus concluded that the absence of ERR&#x003b1; enhanced the osteoblastic differentiation of bone marrow cells without modifying their proliferation capacities. This is in agreement with recent results showing that the inhibition of ERR&#x003b1; expression in mammary cells does not modify proliferation <xref ref-type="bibr" rid="pone.0007942-Bianco1">&#x0005b;21&#x0005d;</xref>. Our results are in contrast with previous data suggesting that ERR&#x003b1; promotes osteoblast differentiation <xref ref-type="bibr" rid="pone.0007942-Bonnelye3">&#x0005b;34&#x0005d;</xref>. However, it is worth noting that our study analyzed femoral mesenchymal cells (which form endochondral bone, <italic>i.e.</italic> requiring a cartilage anlagen) derived from ERR&#x003b1;KO mice, whereas Bonnelye et al. <xref ref-type="bibr" rid="pone.0007942-Bonnelye3">&#x0005b;34&#x0005d;</xref> used transiently transfected rat calvarial cells (which form intramembranous bone). These methodological differences might account for the apparent discrepancies found between both studies. In contrast, our data are in agreement with published results in which MSCs originating from an independent ERR&#x003b1;KO strain were found more prone to differentiate into osteoblasts <xref ref-type="bibr" rid="pone.0007942-Delhon1">&#x0005b;35&#x0005d;</xref>. Interestingly this report also show that ERR&#x003b1; concomitantly promotes adipocyte differentiation of MSCs, suggesting that the receptor modulates an inverse relationship between adipogenic and osteogenic commitment of MSCs. In further support of our data, it is also worth noting that the closely related ERR&#x003b3; receptor has recently been found to inhibit BMP2-induced osteoblast differentiation <italic>in vitro</italic> as well as BMP2-induced ectopic bone formation <italic>in vivo</italic><xref ref-type="bibr" rid="pone.0007942-Jeong1">&#x0005b;36&#x0005d;</xref>. Elevated osteoblast differentiation <italic>ex vivo</italic> in the absence of ERR&#x003b1; is furthermore consistent with the more elevated BFR found <italic>in vivo</italic> in ERR&#x003b1;KO mice. Furthermore, opn has been shown to inhibit bone mineralization <xref ref-type="bibr" rid="pone.0007942-Reinholt1">&#x0005b;24&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="pone.0007942-Kavukcuoglu1">&#x0005b;30&#x0005d;</xref>. A lower level of opn expression in the absence of ERR&#x003b1; could thus result in higher mineralization as observed in aging ERR&#x003b1;KO mice.</p><fig id="pone-0007942-g003" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0007942.g003</object-id><label>Figure 3</label><caption><title><italic>Ex vivo</italic> differentiation of bone marrow osteoblast precursors originating from ERR&#x003b1;KO mice.</title><p><bold>A</bold>) Upper panels: Alkaline phosphatase (ALP)- and von Kossa staining after 7 d and 21 d, respectively, in differentiation medium. Lower panel: expression of osteoblast differentiation markers measured by QPCR after 7 d in differentiation medium. Data are expressed relative to wild type level. Ocn: osteocalcin; opn: osteopontin. <bold>B</bold>) Time course of ALP expression after switch to differentation medium in wild type- (white bars) and ERR&#x003b1;KO- (black bars) originating cells measured by QPCR. Data are expressed relative to wild type level at d0. <bold>C</bold>) Rescue of the differentiation phenotype by infection with an ERR&#x003b1;-encoding <italic>vs</italic> a GFP-encoding adenovirus. Upper panel: ALP staining; lower panel: expression of osteoblast differentiation markers determined by QPCR. Adenoviruses were added together with the differentiation medium and the experiment was stopped after 7 d. Data are expressed relative to AdGFP infected cells. <bold>D</bold>) Proliferation of osteoblast precursors. Upper left panel: time course of cell number; lower left panel: time course of ALP staining; right panel: time course of ALP enzymatic activity relative to protein content. Time is indicated after switch to differentiation medium. All experiments were performed at least three times using female bone marrow. Staining views represent a single typical experiment; expression data and cell counting represent a typical experiment performed in triplicate with error bars indicating S.D.</p></caption><graphic xlink:href="pone.0007942.g003"/></fig></sec><sec id="s2c"><title>ERR&#x003b1; Deficiency Protects Females from Bone Loss Resulting from Sex Hormone Ablation</title><p>Normal aging causes a moderate bone loss as the result of a progressive imbalance between bone formation and bone resorption. This equilibrium is also disrupted in favor of bone resorption upon sex hormone deficiency which leads to a severe bone loss, as can be observed in women after menopause or in mice after ovariectomy. Since bone formation is more elevated in ERR&#x003b1;KO we hypothesized that this phenomenon might compensate for the remodeling imbalance induced by sex-hormone withdrawal. Gonadectomized wild type females showed an important decrease of relative bone volume (<xref ref-type="fig" rid="pone-0007942-g004">Fig. 4A</xref>) and trabecular number (<xref ref-type="fig" rid="pone-0007942-g004">Fig. 4B</xref>) four wks after surgery. Strikingly, none of these parameters were significantly affected in ovariectomized ERR&#x003b1;KO animals, indicating that cancellous bone was preserved in mutant mice. Bone formation rate was enhanced in wt females as marker of enhanced bone remodeling (<xref ref-type="fig" rid="pone-0007942-g004">Fig. 4C</xref>). In contrast, this parameter did not vary in ERR&#x003b1;KO mice according to the hormonal status. In males, orchidectomy resulted in similar variations in mineral density, bone volume and trabecular number in wild type and mutant mice (<xref ref-type="table" rid="pone-0007942-t001">Table 1</xref>), indicating suggesting that bone was equally affected, independently of the genotype. We thus concluded that the absence of ERR&#x003b1; completely protects against the bone loss induced by deficiency in sex hormone action in females, but not in males.</p><fig id="pone-0007942-g004" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0007942.g004</object-id><label>Figure 4</label><caption><title>Bone structural parameters of ovariectomized ERR&#x003b1;KO mice.</title><p>Bone volume fraction (BV/TV; <bold>A</bold>), trabecular number (TbN; <bold>B</bold>), and bone formation rate (BFR; <bold>C</bold>) were determined in the femur 4 wk after surgery (performed at 10 wk of age) in sham (white bars) or ovariectomized (black bars) wild type and ERR&#x003b1;KO mice. n: 8. Errors bars represent s.e.m. ns: not significant; &#x0002a;:p&#x0003c;0.05; &#x0002a;&#x0002a;&#x0002a; p&#x0003c;0.005.</p></caption><graphic xlink:href="pone.0007942.g004"/></fig><p>The mechanisms responsible for this phenomenon are not identified but it is tempting to speculate that <italic>i</italic>) the higher differentiation capacities of MSCs in osteoblasts in the absence of ERR&#x003b1; as well as <italic>ii</italic>) the low expression of opn in ERR&#x003b1;KO osteoblasts could be involved in sparing bone under estrogen deficiency challenge. Indeed, it has been shown that opn-deficient mice are resistant to ovariectomy-induced bone loss <xref ref-type="bibr" rid="pone.0007942-Yoshitake1">&#x0005b;37&#x0005d;</xref>.</p><p>In summary, our data show that the absence of ERR&#x003b1; leads to a resistance in age- as well as estrogen-deficiency-dependent bone loss exclusively in female mice. This finding may have important consequences for the treatment of osteoporosis following menopause, and will need careful investigation to unravel the mechanisms through which ERR&#x003b1; acts in osteoblast differentiation and bone mineralization <italic>in vivo</italic>.</p></sec></sec><sec sec-type="materials|methods" id="s3"><title>Materials and Methods</title><sec id="s3a"><title>Animals</title><p>ERR&#x003b1;KO animals have been described elsewhere <xref ref-type="bibr" rid="pone.0007942-Luo1">&#x0005b;38&#x0005d;</xref>. All animal experiments were performed in the Plateau de Biologie Experimentale de la Souris (PBES; ENS Lyon) under Animal care procedures, conducted in accordance with the guidelines set by the European Community Council Directives (86/609/EEC) and approved by the local ethical committee. Animals were in C57black6 background and, except were stated, had access to food and water <italic>ad libitum</italic>. Mice were sacrificed by cervical dislocation at 10 a.m.</p><p>For surgery, animals were anesthetized with sodium pentobarbital. Testes were ligatured and cut through an incision in the scrotum. Ovaries were removed through an incision in the flanks. Animals were sacrificied 4 wk after operation. Statistical significance was analyzed using one-way ANOVA.</p></sec><sec id="s3b"><title>X-ray Micro-Computed Tomography Analysis</title><p>3D microarchitecture of the femur was evaluated using a high-resolution (8 &#x000b5;m) microtomographic imaging system (eXplore Locus, GE, USA). A 3D region within the secondary spongiosa in the proximal metaphysis of the femur was reconstructed, beginning 500 &#x000b5;m proximal to the growth plate and extending to 1.5 mm. Cortical bone was reconstructed from a 1 mm thick region of interest centered on the diaphysis, 5 mm distal from the proximal growth plate. Morphometric parameters were computed using the Advanced Bone Analysis Microview Software (GE).</p></sec><sec id="s3c"><title>Histomorphometric Analysis</title><p>For histological analyses, undecalcified bones were fixed, deshydrated in ethanol solutions at 4&#x000b0;C and embedded in methyl-methacrylate according to standard protocols. For each femur, 7 &#x000b5;m thick longitudinal sections, parallel to the sagittal plane, were prepared. Bone sections were stained with von Kossa/van Giseon reagent, images were captured using a Nikon eclipse 80i microscope and analyzed using NIS Elements AR 2.30 software (Nikon). To determine bone formation parameters, calcein (10 mg/kg body weight) was injected to mice i.p. 5 and 2 d before sacrifice. Bone formation rate was calculated as interlabeled widths/interval time. To determine bone resorption parameters, sections were stained for tartrate-resistant acid phosphatase (TRAP). TRAP-positive multinucleated cells attached to bone were scored as osteoclasts and results were expressed as number of osteoclasts per trabecular bone perimeter. Bone-related degradation products from Collagen 1 (Ctx) in serum were measured by immunosorbent assay, using a RatLaps ELISA kit from Nordic Bioscience Diagnostics A/S (Herlev, Denmark), following the recommendations of the manufacturers. Measurements were performed after overnight fasting.</p></sec><sec id="s3d"><title>Bone Marrow Cultures</title><p>Primary MSCs were collected from bone marrow of femur and tibia of 12-week old mice and cultured in six-well dishes (4&#x000d7;10<sup>6</sup> cells/well) in MEM&#x003b1; containing 10&#x00025; fetal calf serum with 100 U/ml penicillin G and 100 &#x000b5;g/ml streptomycin. For osteoblastic differentiation, after 5 d of culture the medium was supplemented with 50 &#x000b5;g/ml L-ascorbic acid and 10 mM &#x003b2;-glycerophosphate and replaced every 2 to 3 days for 3, 7, 14 or 21 days. Osteoblastic differentiation was evaluated by ALP staining and ALP enzymatic activity. For ALP staining, cells were rinsed twice with PBS, and then fixed with 4&#x00025; (v/v) formaldehyde for 5 min. After 3 washes with H<sub>2</sub>O, cells were incubated 30 min with Fast Blue RR salt and Naphtol AS-MX Phosphate Alkaline solution 0,25&#x00025; (Sigma Aldrich) in the dark. For ALP enzymatic activity measurement, cells were lysed with Lysis Buffer (50 mM Tris, HCl pH 7,5; 0,1&#x00025; Triton-X100; 0,9&#x00025; NaCl). Cell lysates were incubated with 0,2 M of Naphtol Alkaline solution (Sigma Aldrich) and the conversion of <italic>p</italic>-nitrophenyl phosphate to <italic>p</italic>-nitrophenol was spectrophotometrically determined and normalized to cellular protein content by using detergent compatible Bradford reagent (Pierce). For proliferation tests, viable cells were visually counted after resuspension and trypan blue coloration. Adenoviral vectors expressing GFP or ERR&#x003b1; have been previously described <xref ref-type="bibr" rid="pone.0007942-Schreiber1">&#x0005b;39&#x0005d;</xref> and kindly donated by Anastasia Kralli.</p></sec><sec id="s3e"><title>Expression Analysis</title><p>RNAs were purified using Guanidinium thiocyanate/phenol/chloroforme extraction. Total RNAs were reverse transcribed using Superscript II retrotranscription kit (Invitrogen). Quantitative PCR were performed using the SYBR GREEN Jump Start kit (Sigma Aldrich) in duplicate on an ABI apparatus using standard procedure. Expression data were normalized to the expression of the 36b4 housekeeping gene. Sequence of the primers used in this study:</p><p>36b4: <named-content content-type="gene">5&#x02032;-ACCTCCTTCTTCCAGGCTTT-3&#x02032;</named-content> and <named-content content-type="gene">5&#x02032;-CCCACCTTGTCTCCAGTCTTT-3&#x02032;</named-content>; ALP: <named-content content-type="gene">5&#x02032;-GCCCTCCAGATCCTGACCAA-3&#x02032;</named-content> and <named-content content-type="gene">5&#x02032;- GCAGAGCCTGCTGGTCCTTA-3&#x02032;</named-content>; ERR&#x003b1;: <named-content content-type="gene">5&#x02032;-CAAACGCCTCTGCCTGGTCT-3&#x02032;</named-content> and <named-content content-type="gene">5&#x02032;-ACTCGATGCTCCCCTGGATG-3&#x02032;</named-content>; OCN: <named-content content-type="gene">5&#x02032;-ACCTCACAGATGCCAAGCCC-3&#x02032;</named-content> and <named-content content-type="gene">5&#x02032;-AGCGCCGGAGTCTGTTCACT-3&#x02032;</named-content>; OPN: <named-content content-type="gene">5&#x02032;-TCTCCTTGCGCCACAGAATG-3&#x02032;</named-content> and <named-content content-type="gene">5&#x02032;-TCGTCCATGTGGTCATGGCT-3&#x02032;</named-content>; Runx-2: <named-content content-type="gene">5&#x02032;-GACGTGCCCAGGCGTATTTC-3&#x02032;</named-content> and <named-content content-type="gene">5&#x02032;-GGAACTGCCTGGGGTCTGAA-3&#x02032;</named-content>.</p></sec></sec></body><back><ack><p>We thank Anastasia Kralli for the gift of adenovirus vectors. We thank the personnel of the PBES, ENS Lyon, for helping in performing animal experimentations.</p></ack><ref-list><title>References</title><ref id="pone.0007942-Ducy1"><label>1</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ducy</surname><given-names>P</given-names></name><name><surname>Zhang</surname><given-names>R</given-names></name><name><surname>Geoffroy</surname><given-names>V</given-names></name><name><surname>Rydall</surname><given-names>AL</given-names></name><name><surname>Karsenty</surname><given-names>G</given-names></name></person-group><year>1997</year><article-title>Osf2/Cbfa1, a transcriptional regulator of osteoblast differentiation.</article-title><source>Cell</source><volume>8</volume><fpage>747</fpage><lpage>754</lpage><pub-id pub-id-type="pmid">9182762</pub-id></mixed-citation></ref><ref id="pone.0007942-Nakashima1"><label>2</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nakashima</surname><given-names>K</given-names></name><name><surname>Zhou</surname><given-names>X</given-names></name><name><surname>Kunkel</surname><given-names>G</given-names></name><name><surname>Zhang</surname><given-names>Z</given-names></name><name><surname>Deng</surname><given-names>JM</given-names></name><etal/></person-group><year>2002</year><article-title>The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation.</article-title><source>Cell</source><volume>108</volume><fpage>17</fpage><lpage>29</lpage><pub-id pub-id-type="pmid">11792318</pub-id></mixed-citation></ref><ref id="pone.0007942-Komori1"><label>3</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Komori</surname><given-names>T</given-names></name></person-group><year>2006</year><article-title>Regulation of osteoblast differentiation by transcription factors.</article-title><source>J Cell Biochem</source><volume>99</volume><fpage>1233</fpage><lpage>1239</lpage><pub-id pub-id-type="pmid">16795049</pub-id></mixed-citation></ref><ref id="pone.0007942-Kostenuik1"><label>4</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kostenuik</surname><given-names>PJ</given-names></name></person-group><year>2005</year><article-title>Osteoprotegerin and RANKL regulate bone resorption, density, geometry and strength.</article-title><source>Curr Opin Pharmacol</source><volume>5</volume><fpage>618</fpage><lpage>625</lpage><pub-id pub-id-type="pmid">16188502</pub-id></mixed-citation></ref><ref id="pone.0007942-Xing1"><label>5</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xing</surname><given-names>L</given-names></name><name><surname>Schwarz</surname><given-names>EM</given-names></name><name><surname>Boyce</surname><given-names>BF</given-names></name></person-group><year>2005</year><article-title>Osteoclast precursors, RANKL/RANK, and immunology.</article-title><source>Immunol Rev</source><volume>208</volume><fpage>19</fpage><lpage>29</lpage><pub-id pub-id-type="pmid">16313338</pub-id></mixed-citation></ref><ref id="pone.0007942-Wada1"><label>6</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wada</surname><given-names>T</given-names></name><name><surname>Nakashima</surname><given-names>T</given-names></name><name><surname>Hiroshi</surname><given-names>N</given-names></name><name><surname>Penninger</surname><given-names>JM</given-names></name></person-group><year>2006</year><article-title>RANKL-RANK signaling in osteoclastogenesis and bone disease.</article-title><source>Trends Endocrinol Metab</source><volume>12</volume><fpage>17</fpage><lpage>25</lpage></mixed-citation></ref><ref id="pone.0007942-Asagiri1"><label>7</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Asagiri</surname><given-names>M</given-names></name><name><surname>Takayanagi</surname><given-names>H</given-names></name></person-group><year>2006</year><article-title>The molecular understanding of osteoclast differentiation.</article-title><source>Bone</source><volume>40</volume><fpage>251</fpage><lpage>264</lpage><pub-id pub-id-type="pmid">17098490</pub-id></mixed-citation></ref><ref id="pone.0007942-Simonet1"><label>8</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Simonet</surname><given-names>WS</given-names></name><name><surname>Lacey</surname><given-names>DL</given-names></name><name><surname>Dunstan</surname><given-names>CR</given-names></name><name><surname>Kelley</surname><given-names>M</given-names></name><name><surname>Chang</surname><given-names>MS</given-names></name><etal/></person-group><year>1997</year><article-title>Osteoprotegerin: a novel secreted protein involved in the regulation of bone density.</article-title><source>Cell</source><volume>89</volume><fpage>309</fpage><lpage>19</lpage><pub-id pub-id-type="pmid">9108485</pub-id></mixed-citation></ref><ref id="pone.0007942-Boyce1"><label>9</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boyce</surname><given-names>BF</given-names></name><name><surname>Xing</surname><given-names>L</given-names></name></person-group><year>2008</year><article-title>Functions of RANKL/RANK/OPG in bone modeling and remodeling.</article-title><source>Arch Biochem Biophys</source><volume>473</volume><fpage>139</fpage><lpage>146</lpage><pub-id pub-id-type="pmid">18395508</pub-id></mixed-citation></ref><ref id="pone.0007942-Syed1"><label>10</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Syed</surname><given-names>F</given-names></name><name><surname>Khosla</surname><given-names>S</given-names></name></person-group><year>2004</year><article-title>Mechanisms of sex steroid effects on bone.</article-title><source>Biochem Biophys Res Commun</source><volume>328</volume><fpage>688</fpage><lpage>696</lpage><pub-id pub-id-type="pmid">15694402</pub-id></mixed-citation></ref><ref id="pone.0007942-Raisz1"><label>11</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Raisz</surname><given-names>LG</given-names></name></person-group><year>2005</year><article-title>Pathogenesis of osteoporosis: concepts, conflicts, and prospects.</article-title><source>J Clin Invest</source><volume>115</volume><fpage>3318</fpage><lpage>3325</lpage><pub-id pub-id-type="pmid">16322775</pub-id></mixed-citation></ref><ref id="pone.0007942-Laudet1"><label>12</label><mixed-citation publication-type="other"><person-group person-group-type="author"><name><surname>Laudet</surname><given-names>V</given-names></name><name><surname>Gronemeyer</surname><given-names>H</given-names></name></person-group><year>2002</year><article-title>The nuclear receptor factbook.</article-title><comment>Academic press: San Diego</comment></mixed-citation></ref><ref id="pone.0007942-Gigure1"><label>13</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gigu&#x000e8;re</surname><given-names>V</given-names></name></person-group><year>1999</year><article-title>Orphan nuclear receptors: from gene to function.</article-title><source>Endocr Rev</source><volume>20</volume><fpage>689</fpage><lpage>725</lpage><pub-id pub-id-type="pmid">10529899</pub-id></mixed-citation></ref><ref id="pone.0007942-Gigure2"><label>14</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gigu&#x000e8;re</surname><given-names>V</given-names></name><name><surname>Yang</surname><given-names>N</given-names></name><name><surname>Segui</surname><given-names>P</given-names></name><name><surname>Evans</surname><given-names>RM</given-names></name></person-group><year>1988</year><article-title>Identification of a new class of steroid hormone receptors.</article-title><source>Nature</source><volume>331</volume><fpage>91</fpage><lpage>94</lpage><pub-id pub-id-type="pmid">3267207</pub-id></mixed-citation></ref><ref id="pone.0007942-Tremblay1"><label>15</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tremblay</surname><given-names>AM</given-names></name><name><surname>Gigu&#x000e8;re</surname><given-names>V</given-names></name></person-group><year>2007</year><article-title>The NR3B subgroup: an ovERRview.</article-title><source>Nucl Recept Signal</source><volume>5</volume><fpage>e009</fpage><pub-id pub-id-type="pmid">18174917</pub-id></mixed-citation></ref><ref id="pone.0007942-Horard1"><label>16</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Horard</surname><given-names>B</given-names></name><name><surname>Vanacker</surname><given-names>JM</given-names></name></person-group><year>2003</year><article-title>Estrogen receptor-related receptors: orphan receptors desperately seeking a ligand.</article-title><source>J Mol Endocrinol</source><volume>31</volume><fpage>349</fpage><lpage>357</lpage><pub-id pub-id-type="pmid">14664699</pub-id></mixed-citation></ref><ref id="pone.0007942-Bonnelye1"><label>17</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bonnelye</surname><given-names>E</given-names></name><name><surname>Vanacker</surname><given-names>JM</given-names></name><name><surname>Spruyt</surname><given-names>N</given-names></name><name><surname>Alric</surname><given-names>S</given-names></name><name><surname>Fournier</surname><given-names>B</given-names></name><etal/></person-group><year>1997</year><article-title>Expression of the estrogen related receptor 1 (ERR-1) orphan receptor during mouse development.</article-title><source>Mech Dev</source><volume>65</volume><fpage>71</fpage><lpage>85</lpage><pub-id pub-id-type="pmid">9256346</pub-id></mixed-citation></ref><ref id="pone.0007942-Gigure3"><label>18</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gigu&#x000e8;re</surname><given-names>V</given-names></name></person-group><year>2008</year><article-title>Transcriptional control of energy homeostasis by the estrogen related receptors.</article-title><source>Endocr Rev</source><volume>29</volume><fpage>677</fpage><lpage>696</lpage><pub-id pub-id-type="pmid">18664618</pub-id></mixed-citation></ref><ref id="pone.0007942-Villena1"><label>19</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Villena</surname><given-names>JA</given-names></name><name><surname>Kralli</surname><given-names>A</given-names></name></person-group><year>2008</year><article-title>ERRalpha: a metabolic function for the oldest orphan.</article-title><source>Trends Endocrinol Metab</source><volume>19</volume><fpage>269</fpage><lpage>76</lpage><pub-id pub-id-type="pmid">18778951</pub-id></mixed-citation></ref><ref id="pone.0007942-Ariazi1"><label>20</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ariazi</surname><given-names>EA</given-names></name><name><surname>Jordan</surname><given-names>VC</given-names></name></person-group><year>2006</year><article-title>Estrogen-related receptors as emerging targets in cancer and metabolic disorders.</article-title><source>Curr Top Med Chem</source><volume>6</volume><fpage>203</fpage><lpage>215</lpage><pub-id pub-id-type="pmid">16515477</pub-id></mixed-citation></ref><ref id="pone.0007942-Bianco1"><label>21</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bianco</surname><given-names>S</given-names></name><name><surname>Lanvin</surname><given-names>O</given-names></name><name><surname>Tribollet</surname><given-names>V</given-names></name><name><surname>Macari</surname><given-names>C</given-names></name><name><surname>North</surname><given-names>S</given-names></name><etal/></person-group><year>2009</year><article-title>Modulating ERRalpha activity inhibits cell proliferation.</article-title><source>J Biol Chem</source><volume>284</volume><fpage>23286</fpage><lpage>23292</lpage><pub-id pub-id-type="pmid">19546226</pub-id></mixed-citation></ref><ref id="pone.0007942-Bonnelye2"><label>22</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bonnelye</surname><given-names>E</given-names></name><name><surname>Vanacker</surname><given-names>JM</given-names></name><name><surname>Dittmar</surname><given-names>T</given-names></name><name><surname>Begue</surname><given-names>A</given-names></name><name><surname>Desbiens</surname><given-names>X</given-names></name><etal/></person-group><year>1997</year><article-title>The ERR-1 orphan receptor is a transcriptional activator expressed during bone development.</article-title><source>Mol Endocrinol</source><volume>11</volume><fpage>905</fpage><lpage>916</lpage><pub-id pub-id-type="pmid">9178750</pub-id></mixed-citation></ref><ref id="pone.0007942-Laflamme1"><label>23</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Laflamme</surname><given-names>N</given-names></name><name><surname>Giroux</surname><given-names>S</given-names></name><name><surname>Loredo-Osti</surname><given-names>JC</given-names></name><name><surname>Elfassihi</surname><given-names>L</given-names></name><name><surname>Dodin</surname><given-names>S</given-names></name><etal/></person-group><year>2005</year><article-title>A frequent regulatory variant of the estrogen-related receptor alpha gene associated with BMD in French-Canadian premenopausal women.</article-title><source>J Bone Miner Res</source><volume>20</volume><fpage>938</fpage><lpage>944</lpage><pub-id pub-id-type="pmid">15883633</pub-id></mixed-citation></ref><ref id="pone.0007942-Reinholt1"><label>24</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reinholt</surname><given-names>FP</given-names></name><name><surname>Hultenby</surname><given-names>K</given-names></name><name><surname>Oldberg</surname><given-names>A</given-names></name><name><surname>Heingard</surname><given-names>D</given-names></name></person-group><year>1990</year><article-title>Osteopontin, a possible anchor of osteoblasts to bone.</article-title><source>Proc Natl Acad Sci USA</source><volume>87</volume><fpage>4473</fpage><lpage>4475</lpage><pub-id pub-id-type="pmid">1693772</pub-id></mixed-citation></ref><ref id="pone.0007942-Ross1"><label>25</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ross</surname><given-names>FP</given-names></name><name><surname>Chappel</surname><given-names>J</given-names></name><name><surname>Alvarez</surname><given-names>JI</given-names></name><name><surname>Sander</surname><given-names>D</given-names></name><name><surname>Buttler</surname><given-names>WT</given-names></name><etal/></person-group><year>1993</year><article-title>Interactions between the bone matrix proteins osteopontin and bone sialoprotein and the osteoclast integrin &#x003b1;v&#x003b2;3 potentiate bone resorption.</article-title><source>J Biol Chem</source><volume>268</volume><fpage>9901</fpage><lpage>9907</lpage><pub-id pub-id-type="pmid">8486670</pub-id></mixed-citation></ref><ref id="pone.0007942-Ishijima1"><label>26</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ishijima</surname><given-names>M</given-names></name><name><surname>Rittling</surname><given-names>SR</given-names></name><name><surname>Yamashite</surname><given-names>T</given-names></name><name><surname>Tsuji</surname><given-names>K</given-names></name><name><surname>Kurosawa</surname><given-names>H</given-names></name><etal/></person-group><year>2001</year><article-title>Enhancement of osteoclastic bone resorption and suppression of osteoblastic bone formation in response to reduced mechanical stress do not occur in the absence of osteopontin.</article-title><source>J Exp Med</source><volume>193</volume><fpage>399</fpage><lpage>404</lpage><pub-id pub-id-type="pmid">11157060</pub-id></mixed-citation></ref><ref id="pone.0007942-Noda1"><label>27</label><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Noda</surname><given-names>M</given-names></name><name><surname>Denhardt</surname><given-names>DT</given-names></name></person-group><year>2002</year><article-title>Osteopontin.</article-title><person-group person-group-type="editor"><name><surname>Bilezikian</surname><given-names>JP</given-names></name><name><surname>Raisz</surname><given-names>LG</given-names></name><name><surname>Rodan</surname><given-names>GA</given-names></name></person-group><source>Principle of bone biology, 2<sup>nd</sup> ed</source><publisher-loc>San Diego</publisher-loc><publisher-name>Academic Press</publisher-name><fpage>239</fpage><lpage>250</lpage><comment>vol1,</comment></mixed-citation></ref><ref id="pone.0007942-Boskey1"><label>28</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boskey</surname><given-names>AL</given-names></name><name><surname>Spevak</surname><given-names>L</given-names></name><name><surname>Paschalis</surname><given-names>E</given-names></name><name><surname>Doty</surname><given-names>SD</given-names></name><name><surname>McKee</surname><given-names>MD</given-names></name></person-group><year>2002</year><article-title>Osteopontin deficiency increases mineral content and mineral crystallinity in mouse bone.</article-title><source>Calcif Tissue Int</source><volume>71</volume><fpage>145</fpage><lpage>154</lpage><pub-id pub-id-type="pmid">12073157</pub-id></mixed-citation></ref><ref id="pone.0007942-Shapses1"><label>29</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shapses</surname><given-names>SA</given-names></name><name><surname>Cifuentes</surname><given-names>M</given-names></name><name><surname>Spevak</surname><given-names>L</given-names></name><name><surname>Chowdury</surname><given-names>H</given-names></name><name><surname>Brittingham</surname><given-names>J</given-names></name><etal/></person-group><year>2003</year><article-title>Osteopontin facilitates bone resorption, decreasing bone mineral crystallinity and content during calcium deficiency.</article-title><source>Calcif Tissue Int</source><volume>73</volume><fpage>86</fpage><lpage>92</lpage><pub-id pub-id-type="pmid">14506959</pub-id></mixed-citation></ref><ref id="pone.0007942-Kavukcuoglu1"><label>30</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kavukcuoglu</surname><given-names>NB</given-names></name><name><surname>Denhardt</surname><given-names>DT</given-names></name><name><surname>Guzelsu</surname><given-names>N</given-names></name><name><surname>Mann</surname><given-names>AB</given-names></name></person-group><year>2007</year><article-title>Osteopontin deficiency and aging on nanomechanics of mouse bone.</article-title><source>J Biomed Mater Res A</source><volume>83</volume><fpage>136</fpage><lpage>144</lpage><pub-id pub-id-type="pmid">17390367</pub-id></mixed-citation></ref><ref id="pone.0007942-Vanacker1"><label>31</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vanacker</surname><given-names>JM</given-names></name><name><surname>Delmarre</surname><given-names>C</given-names></name><name><surname>Guo</surname><given-names>X</given-names></name><name><surname>Laudet</surname><given-names>V</given-names></name></person-group><year>1998</year><article-title>Activation of the osteopontin promoter by the orphan nuclear receptor estrogen receptor related alpha.</article-title><source>Cell Growth Differ</source><volume>9</volume><fpage>1007</fpage><lpage>1014</lpage><pub-id pub-id-type="pmid">9869301</pub-id></mixed-citation></ref><ref id="pone.0007942-Vanacker2"><label>32</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vanacker</surname><given-names>JM</given-names></name><name><surname>Pettersson</surname><given-names>K</given-names></name><name><surname>Gustafsson</surname><given-names>JA</given-names></name><name><surname>Laudet</surname><given-names>V</given-names></name></person-group><year>1999</year><article-title>Transcriptional targets shared by estrogen receptor- related receptors (ERRs) and estrogen receptor (ER) alpha, but not by ERbeta.</article-title><source>EMBO J</source><volume>18</volume><fpage>4270</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">10428965</pub-id></mixed-citation></ref><ref id="pone.0007942-Zirngibl1"><label>33</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zirngibl</surname><given-names>RA</given-names></name><name><surname>Chan</surname><given-names>JS</given-names></name><name><surname>Aubin</surname><given-names>JE</given-names></name></person-group><year>2008</year><article-title>Estrogen receptor-related receptor alpha (ERRalpha) regulates osteopontin expression through a non-canonical ERRalpha response element in a cell context-dependent manner.</article-title><source>J Mol Endocrinol</source><volume>40</volume><fpage>61</fpage><lpage>73</lpage><pub-id pub-id-type="pmid">18234909</pub-id></mixed-citation></ref><ref id="pone.0007942-Bonnelye3"><label>34</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bonnelye</surname><given-names>B</given-names></name><name><surname>Merdad</surname><given-names>L</given-names></name><name><surname>Kung</surname><given-names>V</given-names></name><name><surname>Aubin</surname><given-names>JE</given-names></name></person-group><year>2001</year><article-title>The orphan nuclear estrogen receptor-related receptor &#x003b1; (ERR&#x003b1;) is expressed throughout osteoblast differentiation and regulates bone formation in vitro.</article-title><source>J Cell Biol</source><volume>153</volume><fpage>971</fpage><lpage>983</lpage><pub-id pub-id-type="pmid">11381083</pub-id></mixed-citation></ref><ref id="pone.0007942-Delhon1"><label>35</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Delhon</surname><given-names>I</given-names></name><name><surname>Gutzwiller</surname><given-names>S</given-names></name><name><surname>Morvan</surname><given-names>F</given-names></name><name><surname>Rangwala</surname><given-names>S</given-names></name><name><surname>Wyder</surname><given-names>L</given-names></name><etal/></person-group><year>2009</year><article-title>Absence of estrogen receptor related alpha increases osteoblastic differentiation and cancellous bone mineral density.</article-title><source>Endocrinology</source><volume>150</volume><fpage>4463</fpage><lpage>4472</lpage><pub-id pub-id-type="pmid">19608650</pub-id></mixed-citation></ref><ref id="pone.0007942-Jeong1"><label>36</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jeong</surname><given-names>BC</given-names></name><name><surname>Lee</surname><given-names>YS</given-names></name><name><surname>Park</surname><given-names>YY</given-names></name><name><surname>Bae</surname><given-names>ICH</given-names></name><name><surname>Kim</surname><given-names>DK</given-names></name><etal/></person-group><year>2009</year><article-title>The orphan nuclear receptor Estrogen-receptor-Related Receptor &#x003b3; negatively regulates BMP2-induced osteoblast differentiation and bone formation.</article-title><source>J Biol Chem</source><volume>284</volume><fpage>14211</fpage><lpage>14218</lpage><pub-id pub-id-type="pmid">19324883</pub-id></mixed-citation></ref><ref id="pone.0007942-Yoshitake1"><label>37</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yoshitake</surname><given-names>H</given-names></name><name><surname>Rittling</surname><given-names>SR</given-names></name><name><surname>Denhardt</surname><given-names>DT</given-names></name><name><surname>Noda</surname><given-names>M</given-names></name></person-group><year>1999</year><article-title>Osteopontin-deficient mice are resistant to ovariectomy-induced bone resorption.</article-title><source>Proc Natl Acad Sci USA</source><volume>96</volume><fpage>8156</fpage><lpage>8160</lpage><pub-id pub-id-type="pmid">10393964</pub-id></mixed-citation></ref><ref id="pone.0007942-Luo1"><label>38</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Luo</surname><given-names>J</given-names></name><name><surname>Sladek</surname><given-names>R</given-names></name><name><surname>Carrier</surname><given-names>J</given-names></name><name><surname>Bader</surname><given-names>JA</given-names></name><name><surname>Richard</surname><given-names>D</given-names></name><etal/></person-group><year>2003</year><article-title>Reduced fat mass in mice lacking orphan nuclear receptor estrogen-related receptor &#x003b1;.</article-title><source>Mol Cell Biol</source><volume>23</volume><fpage>7947</fpage><lpage>7956</lpage><pub-id pub-id-type="pmid">14585956</pub-id></mixed-citation></ref><ref id="pone.0007942-Schreiber1"><label>39</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schreiber</surname><given-names>SN</given-names></name><name><surname>Emter</surname><given-names>R</given-names></name><name><surname>Hock</surname><given-names>MB</given-names></name><name><surname>Knutti</surname><given-names>D</given-names></name><name><surname>Cardenas</surname><given-names>J</given-names></name><etal/></person-group><year>2004</year><article-title>The estrogen-related receptor &#x003b1; (ERR&#x003b1;) functions in PPAR&#x003b3; coactivator 1&#x003b1; (PGC-1&#x003b1;)-induced mitochondrial biogenesis.</article-title><source>Proc Natl Acad Sci USA</source><volume>101</volume><fpage>6472</fpage><lpage>6477</lpage><pub-id pub-id-type="pmid">15087503</pub-id></mixed-citation></ref></ref-list><fn-group><fn fn-type="conflict"><p><bold>Competing Interests: </bold>The authors have declared that no competing interests exist.</p></fn><fn fn-type="financial-disclosure"><p><bold>Funding: </bold>This work was supported by Inserm (Programme National de Recherche sur les maladies osteo-articulaires), Agence Nationale pour la Recherche (grant ANR-08-GENOPAT-012). C.T. has been funded by Fondation pour la Recherche Medicale. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</p></fn></fn-group></back></article>